EVRY, France--(BUSINESS WIRE)--

Global Bioenergies, the industrial biology company developing sustainable routes to light olefins, has been selected by EuropaBio, the organization representing more than 1800 European companies, to receive the most innovative European biotech SME award.

As announced previously, Global Bioenergies had been selected as one of the five nominees contending for the most innovative European biotech SME award bestowed by EuropaBio, the principal organization which represents more than 1800 European biotechnology companies. On September 19th 2012, the final awardees chosen by an expert panel were revealed at the award ceremony held in the European Parliament by Commission Vice President Antonio Tajani, Commissioner for Industry & Entrepreneurship.

Global Bioenergies is proud to announce that it has received this prestigious award which was initially opened to all European biotechnology companies active in fields as diverse as pharmaceuticals, diagnostics, plant science, environment and industrial biology. According to Nathalie Moll, EuropaBio General Secretary, this choice was motivated by the innovations developed by Global Bioenergies, but also by their economic potential and their ability to answer some of our societys most pressing needs. The corresponding EuropaBio announcement can be found under: http://www.EuropaBio.org

About GLOBAL BIOENERGIES

Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the yield of its process and prepares the phase dedicated to pilot testing. The company is also looking to replicate this success with other members of the gaseous olefins family (propylene, ethylene, linear butylenes, butadiene), key molecules at the heart of petrochemical industry. Global Bioenergies is listed on NYSE Alternext Paris (FR0011052257 ALGBE).

Should you like to be kept informed, subscribe to our news feed on http://www.global-bioenergies.com

Visit link:
GLOBAL BIOENERGIES Receives the “Most Innovative European Biotech SME” EuropaBio Award